Arrowhead Research | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Arrowhead Research USD 684.22M 631.64M 2025-03
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Ligand Pharmaceuticals USD 795.53M 34.9M 2025-03
Merck USD 48.34B 2.02B 2025-03
Moderna USD 10.07B 835M 2025-03
Novartis USD 44.05B 605M 2024-12
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
TG Therapeutics USD 222.36M 30.21M 2024-12
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Xencor USD 639.87M 37.74M 2025-03



Arrowhead Research Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.